Login
Get Started
Today
Browse
Screens
Folios
Discuss
Learn
Browse
Shares
Healthcare
Biotechnology & Medical Research
Aprea Therapeutics Inc
APRE -
Aprea Therapeutics Inc
News Story
$4.65
0.3 7.6%
Last Trade -
16/04/21
Sector
Healthcare
RiskRating
Speculative
Size
Small Cap
Style
Sucker Stock
Market Cap
£71.2m
Enterprise Value
£6.87m
Revenue
£n/a
Position in Universe
5156th / 6850
Quality
Value
Momentum
Stock
Rank™
StockReport™
Tools
Compare with...
Run through checklist
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
Charts
News
Discussions
APRE Dividends
All News
NASDAQ RESUMED AT 08:31 AM
Aprea Therapeutics Inc
News
Mon 28th December, 2020 1:31pm
NASDAQ RESUMED APRE.O AT 08:31 AM
Recent news on Aprea Therapeutics Inc
See all news
Aprea Therapeutics to Host Virtual R&D Day on April 22, 2021
Fri 2:15pm
News
BRIEF-Aprea Therapeutics Receives FDA Orphan Drug Designation For Eprenetapopt For The Treatment Of Acute Myeloid Leukemia
8th Apr
News
BUZZ-Aprea Therapeutics: Jumps on 'orphan drug' tag for cancer treatment
8th Apr
News
Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)
8th Apr
News
U.S. RESEARCH ROUNDUP- Comcast, Hershey, Oracle
17th Mar
News
Discover the metrics influencing Aprea Therapeutics Inc's share price
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email
© Stockopedia 2021, Refinitiv, Share Data Services.
Facebook
Twitter
Youtube
Instagram
RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our
Terms of Use
,
Privacy
and
Disclaimer
policies.
Discover the metrics influencing Aprea Therapeutics Inc's share price
Unlock
with Google
Unlock with Facebook
Unlock with Email
Unlock
with Google
Unlock
with Facebook
or
Unlock with your email